首页> 外文OA文献 >Efficacy of casopitant, a novel neurokinin-1 receptor antagonist, for antiemesis over repeated cycles of moderately emetogenic chemotherapy

【2h】

Efficacy of casopitant, a novel neurokinin-1 receptor antagonist, for antiemesis over repeated cycles of moderately emetogenic chemotherapy

机译：casopitant，一种新型神经激肽-1受体拮抗剂，在中度致呕性化疗的重复周期中的止呕作用

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Herrstedt Jørn; Russo M W; Lane S;
展开▼
作者单位

展开▼
年度 2009
总页数
原文格式 PDF
正文语种 eng
中图分类

相似文献

外文文献
中文文献
专利

1. 3086 Efficacy of casopitant, a novel NK-1 receptor antagonist, for antiemesis over repeated cycles of moderately emetogenic therapy [J] . J.Herrstedt, M.Russo, S.Lane European Journal of Cancer Supplements . 2009,第2期

机译：3086 casopitant（一种新的NK-1受体拮抗剂）在中度致呕药治疗的重复周期中的止吐功效
2. 3086 Efficacy of casopitant, a novel NK-1 receptor antagonist, for antiemesis over repeated cycles of moderately emetogenic therapy [J] . J.Herrstedt, M.Russo, S.Lane European Journal of Cancer Supplements . 2009,第2期

机译：3086 casopitant（一种新的NK-1受体拮抗剂）在中度致呕药治疗的重复周期中的止吐功效
3. Phase 2 trial results with the novel neurokinin-1 receptor antagonist casopitant in combination with ondansetron and dexamethasone for the prevention of chemotherapy-induced nausea and vomiting in cancer patients receiving moderately emetogenic chemotherapy. [J] . Arpornwirat W, Albert I, Hansen V Cancer: A Journal of the American Cancer Society . 2009,第24期

机译：新型神经激肽-1受体拮抗剂casopitant联合恩丹西酮和地塞米松在预防中度致癌化学疗法的癌症患者中预防化疗引起的恶心和呕吐的2期试验结果。
4. Multicenter phase IV study of palonosetron in the prevention of chemotherapy-induced nausea and vomiting (CINV) in patients with non-Hodgkin lymphomas undergoing repeated cycles of moderately emetogenic chemotherapy [O] . Brian S. Choi, Gabriela P. Borsaru, Gianluca Ballinari, -1

机译：帕洛诺司琼预防多发中度致呕性化疗的非霍奇金淋巴瘤患者化疗引起的恶心和呕吐（CINV）的多中心IV期研究
5. Phase 2 trial results with the novel neurokinin-1 receptor antagonist casopitant in combination with ondansetron and dexamethasone for the prevention of chemotherapy-induced nausea and vomiting in cancer patients receiving moderately emetogenic chemotherapy [O] . Wichit Arpornwirat, Istvan Albert, Vincent L. Hansen, 2009

机译：第2阶段试验结果与新型神经喹啉-1受体拮抗剂潜水剂与ondansetron和地塞米松组合用于预防化疗诱导的恶心，癌症患者患者接受中度胰腺化疗的癌症患者

Efficacy of casopitant, a novel neurokinin-1 receptor antagonist, for antiemesis over repeated cycles of moderately emetogenic chemotherapy

著录项

引文网络

相似文献

相关主题

期刊订阅